AngioDynamics, Inc. Finite-Lived Intangible Assets, Net
AngioDynamics, Inc. (ANGO) had Finite-Lived Intangible Assets, Net of $67.21 million as of 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-07-14
- 2026-05-31: Finite-Lived Intangible Assets, Net $67.21M.
- 2026-02-28: Finite-Lived Intangible Assets, Net $65.49M.
- 2025-11-30: Finite-Lived Intangible Assets, Net $66.73M.
- 2025-08-31: Finite-Lived Intangible Assets, Net $68.38M.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2026-05-31 | $67.21M 10-K · filed 2026-07-14 | |
| 2026-02-28 | $65.49M 10-Q · filed 2026-04-02 | |
| 2025-11-30 | $66.73M 10-Q · filed 2026-01-06 | |
| 2025-08-31 | $68.38M 10-Q · filed 2025-10-02 | |
| 2025-05-31 | $69.12M 10-K · filed 2026-07-14 | |
| 2025-02-28 | $70.93M 10-Q · filed 2025-04-02 | |
| 2024-11-30 | $73.11M 10-Q · filed 2025-01-08 | |
| 2024-08-31 | $75.77M 10-Q · filed 2024-10-03 | |
| 2024-05-31 | $77.38M 10-K · filed 2025-07-18 | |
| 2024-02-29 | $81.57M 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $103.89M 10-Q · filed 2024-01-08 | |
| 2023-08-31 | $106.67M 10-Q · filed 2023-10-05 | |
| 2023-05-31 | $111.14M 10-K · filed 2024-07-25 | |
| 2023-02-28 | $134.01M 10-Q · filed 2023-03-31 | |
| 2022-11-30 | $141.94M 10-Q · filed 2023-01-06 | |
| 2022-08-31 | $147.98M 10-Q · filed 2022-10-11 | |
| 2022-05-31 | $152.38M 10-K · filed 2023-08-03 | |
| 2022-02-28 | $159.10M 10-Q · filed 2022-04-07 | |
| 2021-11-30 | $165.00M 10-Q · filed 2022-01-07 | |
| 2021-08-31 | $168.89M 10-Q · filed 2021-09-30 | |
| 2021-05-31 | $168.98M 10-K · filed 2022-07-22 | |
| 2021-02-28 | $186.22M 10-Q · filed 2021-03-31 | |
| 2020-11-30 | $190.56M 10-Q · filed 2021-01-08 | |
| 2020-08-31 | $194.32M 10-Q · filed 2020-10-07 | |
| 2020-05-31 | $197.14M 10-K · filed 2021-07-27 | |
| 2020-02-29 | $201.96M 10-Q · filed 2020-04-08 | |
| 2019-11-30 | $196.32M 10-Q · filed 2020-01-08 | |
| 2019-08-31 | $141.66M 10-Q · filed 2019-10-04 | |
| 2019-05-31 | $145.39M 10-K · filed 2020-08-10 | |
| 2019-02-28 | $166.56M 10-Q · filed 2019-04-02 | |
| 2018-11-30 | $168.71M 10-Q · filed 2019-01-07 | |
| 2018-08-31 | $144.19M 10-Q · filed 2018-10-01 | |
| 2018-05-31 | $112.55M 10-K · filed 2019-07-25 | $130.31M 10-K · filed 2018-07-23 |
| 2018-02-28 | $134.51M 10-Q · filed 2018-04-05 | |
| 2017-11-30 | $137.44M 10-Q · filed 2018-01-05 | |
| 2017-08-31 | $141.58M 10-Q · filed 2017-09-29 | |
| 2017-05-31 | $145.68M 10-K · filed 2018-07-23 | |
| 2017-02-28 | $150.08M 10-Q · filed 2017-04-03 | |
| 2016-11-30 | $154.44M 10-Q · filed 2017-01-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |